巨蟹座:2024年

IF 29.7 1区 医学 Q1 ONCOLOGY
{"title":"巨蟹座:2024年","authors":"","doi":"10.1158/2159-8290.CD-24-1451","DOIUrl":null,"url":null,"abstract":"<p><p>Excerpts from the 14th edition of the annual American Association for Cancer Research Cancer Progress Report (https://cancerprogressreport.aacr.org/progress/) and the third edition of the American Association for Cancer Research Cancer Disparities Progress Report (https://cancerprogressreport.aacr.org/disparities/) to US Congress and the public, both released in 2024, highlight significant strides made possible through medical research, much of which is supported by federal investments in the NIH, NCI, FDA, and Centers for Disease Control and Prevention, as well as recent progress in understanding the overlapping and intersecting causes of cancer disparities and in addressing health inequities through evidence-based public policies.</p>","PeriodicalId":9430,"journal":{"name":"Cancer discovery","volume":"14 12","pages":"2324-2331"},"PeriodicalIF":29.7000,"publicationDate":"2024-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cancer in 2024.\",\"authors\":\"\",\"doi\":\"10.1158/2159-8290.CD-24-1451\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Excerpts from the 14th edition of the annual American Association for Cancer Research Cancer Progress Report (https://cancerprogressreport.aacr.org/progress/) and the third edition of the American Association for Cancer Research Cancer Disparities Progress Report (https://cancerprogressreport.aacr.org/disparities/) to US Congress and the public, both released in 2024, highlight significant strides made possible through medical research, much of which is supported by federal investments in the NIH, NCI, FDA, and Centers for Disease Control and Prevention, as well as recent progress in understanding the overlapping and intersecting causes of cancer disparities and in addressing health inequities through evidence-based public policies.</p>\",\"PeriodicalId\":9430,\"journal\":{\"name\":\"Cancer discovery\",\"volume\":\"14 12\",\"pages\":\"2324-2331\"},\"PeriodicalIF\":29.7000,\"publicationDate\":\"2024-12-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer discovery\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1158/2159-8290.CD-24-1451\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer discovery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1158/2159-8290.CD-24-1451","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

美国癌症研究协会第14版年度癌症进展报告(https://cancerprogressreport.aacr.org/progress/)和美国癌症研究协会第三版癌症差异进展报告(https://cancerprogressreport.aacr.org/disparities/)的节选,均于2024年发布给美国国会和公众,强调了通过医学研究取得的重大进展。其中大部分得到了联邦政府对NIH、NCI、FDA和疾病控制与预防中心的投资的支持,以及最近在了解癌症差异的重叠和交叉原因以及通过基于证据的公共政策解决卫生不公平问题方面取得的进展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Cancer in 2024.

Excerpts from the 14th edition of the annual American Association for Cancer Research Cancer Progress Report (https://cancerprogressreport.aacr.org/progress/) and the third edition of the American Association for Cancer Research Cancer Disparities Progress Report (https://cancerprogressreport.aacr.org/disparities/) to US Congress and the public, both released in 2024, highlight significant strides made possible through medical research, much of which is supported by federal investments in the NIH, NCI, FDA, and Centers for Disease Control and Prevention, as well as recent progress in understanding the overlapping and intersecting causes of cancer disparities and in addressing health inequities through evidence-based public policies.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Cancer discovery
Cancer discovery ONCOLOGY-
CiteScore
22.90
自引率
1.40%
发文量
838
审稿时长
6-12 weeks
期刊介绍: Cancer Discovery publishes high-impact, peer-reviewed articles detailing significant advances in both research and clinical trials. Serving as a premier cancer information resource, the journal also features Review Articles, Perspectives, Commentaries, News stories, and Research Watch summaries to keep readers abreast of the latest findings in the field. Covering a wide range of topics, from laboratory research to clinical trials and epidemiologic studies, Cancer Discovery spans the entire spectrum of cancer research and medicine.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信